Carmen Bollmann

Papers

Total Citations

H-Index

About

Dr. Carmen Bollmann is a leading surgical researcher whose work centers on advancing minimally invasive techniques for complex pancreatic and neuroendocrine conditions, with a particular focus on hereditary cancer syndromes. Her landmark 2016 study, "Minimally Invasive Versus Open Pancreatic Surgery in Patients with Multiple Endocrine Neoplasia Type 1," directly addressed a critical gap in surgical management. By systematically comparing outcomes between minimally invasive and open pancreatic resections in patients with MEN1—a challenging population prone to multiple pancreatic neuroendocrine neoplasms (pNENs)—Bollmann provided the first robust evidence that laparoscopic approaches can offer significant advantages without compromising oncologic safety. This work, cited over 50 times, has helped reshape clinical guidelines and expand surgical options for patients facing lifelong surveillance and repeated interventions. Bollmann’s contributions are particularly valued for their practical impact: she bridges the gap between technical innovation and real-world patient care, demonstrating that less invasive surgery can be both safe and effective in high-risk hereditary settings. Her research continues to influence how surgeons approach pancreatic neuroendocrine tumors, making her a key voice in the evolution of precision surgery for endocrine neoplasia syndromes.